Using quantitative morphometry of the airway wall, it has been demonstrated that IL-33 causes a shift in mast cells from the submucosa to the airway epithelium associated with type 2 inflammation and airway hyperresponsiveness (AHR) [78]. The gene discussed is IL33; the disease is airway hyperresponsiveness.